Kim et al., 2012 - Google Patents
Brain‐derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neuronsKim et al., 2012
View PDF- Document ID
- 12644137826790722828
- Author
- Kim J
- Roberts D
- Hu Y
- Lau G
- Brooks‐Kayal A
- Farb D
- Russek S
- Publication year
- Publication venue
- Journal of Neurochemistry: REVIEW
External Links
Snippet
J. Neurochem.(2012) 120, 210–219. Abstract Regulation of gene expression via brain‐ derived neurotrophic factor (BDNF) is critical to the development of the nervous system and may well underlie cognitive performance throughout life. We now describe a mechanism by …
- 102000004219 Brain-Derived Neurotrophic Factor 0 title abstract description 82
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Brain‐derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons | |
Runge et al. | Dendritic spine plasticity: function and mechanisms | |
Kaltschmidt et al. | NF-κB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling | |
Chen et al. | Wnt5a is essential for hippocampal dendritic maintenance and spatial learning and memory in adult mice | |
Barrett et al. | Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory | |
Wu et al. | Zeb2 recruits HDAC–NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination | |
Zaltieri et al. | α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons | |
Zhu et al. | Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory | |
Brichta et al. | Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update | |
Robison et al. | Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell | |
Su et al. | Atg5-and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine | |
Pérez-Cadahía et al. | Activation and function of immediate-early genes in the nervous system | |
Hamada et al. | Essential role of the nuclear isoform of RBFOX1, a candidate gene for autism spectrum disorders, in the brain development | |
Ferguson et al. | Why calcium-stimulated adenylyl cyclases? | |
Zheng et al. | Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons | |
Helseth et al. | Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice | |
Li et al. | Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome | |
Linnoila et al. | A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction | |
Cheng et al. | SUMO ylation of Me CP 2 is essential for transcriptional repression and hippocampal synapse development | |
Chuang et al. | Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain | |
Di et al. | The role of GABAergic neural circuits in the pathogenesis of autism spectrum disorder | |
Tang et al. | Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer’s disease via C/EBPα/miR‐125b pathway | |
Molinaro et al. | Neuronal NCX1 overexpression induces stroke resistance while knockout induces vulnerability via Akt | |
Markitantova et al. | Inherited eye diseases with retinal manifestations through the eyes of homeobox genes | |
Porro et al. | β‐adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the α‐and γ‐adducin subunits |